Cargando…
Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats
Hepatocellular carcinoma (HCC) is a frequent primary aggressive cancer, a crucial cause of cancer-related mortality globally. Simvastatin is a well-known safe cholesterol-lowering medication that has been recently shown to suppress cancer progression. Apoptosis is a well-organized and controlled cel...
Autores principales: | Elleithi, Yomna A., El-Gayar, Amal M., Amin, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928804/ https://www.ncbi.nlm.nih.gov/pubmed/36367620 http://dx.doi.org/10.1007/s12010-022-04203-0 |
Ejemplares similares
-
Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma
por: Eissa, Laila A., et al.
Publicado: (2013) -
Gastroprotective effects of nebivolol and simvastatin against cold restraint stress-induced gastric ulcer in rats
por: Kamar, Samaa Samir, et al.
Publicado: (2020) -
Simvastatin Induces Apoptosis of Fibroblast-Like Synoviocytes
por: Litinsky, Ira, et al.
Publicado: (2009) -
Simvastatin attenuates chromium-induced nephrotoxicity in rats
por: Goodarzi, Zahra, et al.
Publicado: (2017) -
Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells
por: Lee, Jin, et al.
Publicado: (2016)